featured
Separate and Combined Effects of Semaglutide and Empagliflozin on Kidney Oxygenation and Perfusion in People With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
Diabetologia 2023 May 01;66(5)813-825, S Gullaksen, L Vernstrøm, SS Sørensen, S Ringgaard, C Laustsen, KL Funck, PL Poulsen, E LaugesenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.